Chief Pharmaceutical Inspectorate

Olga Sierpniowska, Director of the Chief Pharmaceutical Inspector’s Office, participated in the debate Medicines from drug programs in ambulatory specialist care (AOS) and community pharmacies – will the reimbursement law reform improve access to treatment?. The discussion brought together healthcare system experts, patient advocates, and clinicians.

– Bringing medicines closer to the patient is an extremely important issue. Today, access to treatment is not so much about technology, but about making responsible decisions. How to make such decisions wisely, with the patient in mind – that was the focus of our discussion – said Olga Sierpniowska, summarising the nearly two-hour debate.

One of the key topics discussed was the proposal to introduce a fourth reimbursement category, which would allow community pharmacies to dispense medicines previously available only through specialised drug programs.

– The planned solutions open new opportunities for patients, as well as for pharmacists to expand their roles. However, any new solution in the system must first be carefully analysed. From the perspective of the Chief Pharmaceutical Inspectorate, the priority is patient safety – and we ensure this through strict oversight of medicine distribution – added Director Sierpniowska.